Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU cross-border healthcare directive nears final approval

This article was originally published in RAJ Devices

Executive Summary

Long-awaited rules on the rights of EU patients to seek medical treatment in other member states have drawn a step closer after a European Parliament committee adopted the draft directive on cross-border healthcare1,2.

You may also be interested in...



Drug Shortages, AMR & Cancer High On New EU Commissioner’s Agenda

The new EU commissioner for health has been given a number of high-priority tasks, including medicines supply and tackling antimicrobial resistance. These topics will be taken up by the European Commission’s advisory body, the Pharmaceutical Committee, in its new work plan.

EU Raises Pressure On Pharmaceutical Pollution Of The Environment

Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.

Richard Torbett to Head Up UK ABPI

Richard Torbett, who negotiated the UK's new voluntary pricing scheme, is to be the new chief executive of the ABPI. 

UsernamePublicRestriction

Register

SC096356

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel